News + Filings Holdings
|
TCG Crossover Management, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
IVERIC bio, Inc.
| ISEE | COM | 2,448,829 | -2,692,289 | 96,336,933,000 | -28,746,468,000 | 15.80 | 1.78 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 23,589,779 | 5,824,566 | 75,723,191,000 | 37,172,679,000 | 12.42 | 4.64 |
Hist
| 06/30/2023 |
Cogent Biosciences, Inc.
| COGT | Common | 5,631,042 | 2,000,000 | 66,671,537,000 | 27,492,594,000 | 10.93 | 7.94 |
Hist
| 06/30/2023 |
VectivBio Holding AG
| VECT | Common | 3,113,600 | 0 | 52,931,200,000 | 26,434,464,000 | 8.68 | |
Hist
| 06/30/2023 |
Aerovate Therapeutics, Inc.
| AVTE | Common | 2,201,274 | 1,120,000 | 37,751,849,000 | 15,942,552,000 | 6.19 | |
Hist
| 06/30/2023 |
Icosavax, Inc.
| ICVX | Common | 3,703,704 | 3,703,704 | 36,777,781,000 | 36,777,781,000 | 6.03 | 8.94 |
Hist
| 06/30/2023 |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | Common | 149,917 | 0 | 34,630,827,000 | -1,688,065,000 | 5.68 | 0.82 |
Hist
| 06/30/2023 |
Tyra Biosciences, Inc.
| TYRA | Common | 1,989,103 | 0 | 33,874,424,000 | 1,909,539,000 | 5.56 | 4.69 |
Hist
| 06/30/2023 |
KalVista Pharmaceuticals, Inc.
| KALV | Common | 3,395,495 | 0 | 30,559,455,000 | 3,870,864,000 | 5.01 | 9.92 |
Hist
| 06/30/2023 |
Ventyx Biosciences, Inc.
| VTYX | Common | 815,724 | 0 | 26,755,747,000 | -571,007,000 | 4.39 | 1.39 |
Hist
| 06/30/2023 |
Dyne Therapeutics, Inc.
| DYN | Common | 1,650,150 | 0 | 18,564,188,000 | -445,540,000 | 3.04 | 2.83 |
Hist
| 06/30/2023 |
Kura Oncology, Inc.
| KURA | Common | 1,423,642 | 0 | 15,062,132,000 | -2,349,010,000 | 2.47 | 2.08 |
Hist
| 06/30/2023 |
Immunovant, Inc.
| | Common | 654,853 | 0 | 12,422,561,000 | 2,265,791,000 | 2.04 | 0.50 |
Hist
| 06/30/2023 |
Silence Therapeutics plc
| SLN | Common | 2,104,875 | 0 | 11,576,813,000 | -1,473,412,000 | 1.90 | 1.95 |
Hist
| 06/30/2023 |
AN2 Therapeutics, Inc.
| ANTX | Common | 1,289,320 | 1,289,320 | 10,959,220,000 | 10,959,220,000 | 1.80 | 6.64 |
Hist
| 06/30/2023 |
Entrada Therapeutics, Inc.
| TRDA | Common | 584,955 | 0 | 8,856,219,000 | 374,371,000 | 1.45 | 1.76 |
Hist
| 06/30/2023 |
Merus N.V.
| MRUS | COM | 300,000 | 0 | 7,899,000,000 | 2,379,000,000 | 1.30 | |
Hist
| 06/30/2023 |
Cabaletta Bio, Inc.
| CABA | Common | 486,795 | 0 | 6,284,523,000 | 2,258,728,000 | 1.03 | 1.55 |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | COM | 529,839 | 0 | 5,494,430,000 | 1,208,032,000 | 0.90 | 0.75 |
Hist
| 06/30/2023 |
C4 Therapeutics, Inc.
| CCCC | Common | 1,276,574 | 26,574 | 3,510,579,000 | -414,421,000 | 0.58 | 2.60 |
Hist
| 06/30/2023 |
ALPINE IMMUNE SCIENCES, INC.
| ALPN | Common | 253,069 | 0 | 2,601,549,000 | 647,856,000 | 0.43 | 0.53 |
Hist
| 06/30/2023 |
CymaBay Therapeutics, Inc.
| CBAY | Common | 0 | -3,048,257 | 0 | -26,580,801,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 0 | -663,610 | 0 | -16,882,238,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|